ICMR transfers 41 public health technologies to Industry

image credit- pib

The Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of Health and Family Welfare, Government of India, recently organised “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect”—India’s largest biomedical and technology transfer facilitation event, at the Manekshaw Centre, New Delhi.

The event marked the establishment of one of the country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative. The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships.

During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released, marking a significant step towards strengthening India’s biomedical innovation, intellectual property and technology transfer ecosystem.

A major highlight of the event was the transfer of 41 public health technologies from ICMR institutes and innovators to industry partners for further development, manufacturing and commercialisation.

These technologies include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities. Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox.

In another significant first, well-characterised biomaterials including inactivated KFD and Chandipura viruses were also transferred to industry partners, strengthening India’s biomedical research and manufacturing ecosystem.

The event also showcased more than 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups, while facilitating direct engagement between innovators and industry stakeholders.